NPY and colitis: A literature analysis showed that the increased expression of NPY was observed during various pathological conditions within the gastrointestinal tract, such as chronic inflammatory bowel disease [45], colitis [13], and proliferative enteropathy [14], which may suggest its modulating effect on inflammation and potentially neuroprotective functions.